ENZC (Enzolytics) Dividends per Share: $0.00 (TTM As of Jun. 2011)


What is Enzolytics Dividends per Share?

Enzolytics ENZC -12.50% Dividends per Share is $0.00 as of Jun. 2011.

Enzolytics's dividends per share for the three months ended in Jun. 2011 was $0.00. Its dividends per share for the trailing twelve months (TTM) ended in Jun. 2011 was $0.00. Its Dividend Payout Ratio for the three months ended in Jun. 2011 was 0.00. As of today, Enzolytics's Dividend Yield % is 0.00%.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

Enzolytics  (OTCPK:ENZC) Dividends per Share Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Enzolytics's Dividend Payout Ratio for the quarter that ended in Jun. 2011 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Jun. 2011 )/ EPS without NRI (Q: Jun. 2011 )
=0/ -5
=N/A

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enzolytics Dividends per Share Related Terms

Enzolytics Dividends per Share Historical Data

* Premium members only.

The historical data trend for Enzolytics's Dividends per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enzolytics Dividends per Share Chart

Enzolytics Annual Data
Trend Dec07 Jul08 Dec09 Dec10
Dividends per Share
0.00 0.00 0.00 0.00

Enzolytics Quarterly Data
Sep07 Dec07 Apr08 Jul08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11
Dividends per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Enzolytics Dividends per Share Competitor Comparison

For the Biotechnology subindustry, Enzolytics's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Enzolytics Dividend Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Enzolytics's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Enzolytics's Dividend Yield % falls into.


Enzolytics Dividends per Share Calculation

Dividends paid to per common share.

Frequently Asked Questions Learn more about Dividends per Share →
What does a Dividends per Share of $0.00 mean?
Enzolytics (ENZC) has a Dividends per Share of $0.00 as of Jun. 2011. Dividends per share represents the per-share amount paid as dividends. View historical data on Enzolytics and its competitors.
Is Enzolytics' Dividends per Share too high?
Enzolytics' current Dividends per Share is $0.00.
How does Enzolytics' Dividends per Share compare to competitors?
Enzolytics' Dividends per Share of $0.00 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividends per Share for a Biotechnology company?
A good Dividends per Share depends on the Biotechnology industry context. However, Dividends per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividends per Share mean?
A high Dividends per Share can signal that a stock is expensive relative to its fundamentals. Dividends per share represents the per-share amount paid as dividends. View historical data on Enzolytics and its competitors. Enzolytics's current Dividends per Share is $0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Enzolytics stock overvalued right now?
Enzolytics (ENZC) has a current Dividends per Share of $0.00. The current Dividends per Share is $0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividends per Share calculated?
Dividends per Share is calculated from a company's financial statements. For Enzolytics (ENZC), the current Dividends per Share is $0.00 as of Jun. 2011. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Enzolytics Business Description

Address 1101 Raintree Circle, Suite 130, Allen, TX, USA, 75013
Enzolytics Inc is a drug development company committed to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases. The company is committed to creating drugs for the good health of mankind. ENZC's flagship compound, ITV-1, is a suspension of Inactivated Pepsin Fragment (IPF), which studies have shown is effective in the treatment of HIV. IPF is the active drug substance of ITV-1 and is a purified extract of porcine pepsin. ITV-1 has been shown to modulate the immune system. IPF is a platform technology that can be used to facilitate a broad range of applications. It is free from neurological, gastrointestinal and hematological side effects seen in the anti-retrovirals in use.